Genentech won’t surrender independence without a fight
August 8, 2008Sales and Marketing
Roche has moved to end its 'arm's length' arrangement with Genentech, offering to buy the remaining shares in the company …
NHS ‘Integrated Care’: from buzzword to reality?
August 8, 2008Primary care professionals have urged the government to fulfil its promise of a new commissioner-led health service, and call for …
NICE set to deny access to kidney cancer drugs
August 8, 2008Sales and Marketing
Four treatments for advanced kidney cancer have been rejected by NICE even though they show significant clinical benefits. The Institute's …
Tracleer wins wider EU licence
August 8, 2008Sales and Marketing
Actelion's Tracleer (bosentan) has been approved in Europe to treat patients with mildly symptomatic pulmonary arterial hypertension (PAH). The move …
Actemra close to US approval
August 8, 2008Sales and Marketing
US regulars have recommended Roche's Actemra (tocilizumab) be approved to treat adults with moderate to severe rheumatoid arthritis (RA). The …
Latest news from Datamonitor
August 5, 2008Research and Development, Sales and Marketing
Biovest/Accentia's BiovaxID revives hope for therapeutic cancer vaccines Biovest, a subsidiary of Accentia, has announced positive data from a pivotal …
Currency lifts Wyeth to 5% growth
July 31, 2008Sales and Marketing
Wyeth saw revenues increase 5% in the second quarter of the year to $5.9 billion, contributing to six month sales …
Sanofi boosts vaccines pipeline with Acambis acquisition
July 31, 2008Sales and Marketing
Sanofi-Aventis has snapped up UK biotech Acambis for £276 million, gaining access to an early-stage pipeline of vaccine candidates targeting …
Lilly’s second quarter marred by prasugrel delay
July 31, 2008Sales and Marketing
A delay to a key new product took the shine off Lilly's strong second quarter, which saw sales increase 11% …
Sanofi sees off rival for Czech generic company
July 31, 2008Sales and Marketing
Sanofi-Aventis' proposed takeover of Zentiva is a step closer to success after its only rival for the Czech generics company …
Sanofi underperforms in second quarter
July 31, 2008Sales and Marketing
Sanofi-Aventis had a below par second quarter and faces a generic threat to sales of top-selling drug Plavix in Germany. …
AstraZeneca boosted by Crestor sales
July 31, 2008Sales and Marketing
AstraZeneca's second quarter sales increased by 9% to $8 billion, as it rode out a 4% drop in US sales …
A new kind of patient advocate
July 30, 2008Sales and Marketing Cancer, campaigner, market access, patient
When I came to interview Kate Spall, it was she, not I, who fired the first few questions. Her approach …
Scepticism over
July 29, 2008NICE will receive a record £100 million from the government in attempt to end the UK's postcode lottery and speed …
The organisational generation gap
July 28, 2008Business Services careers, generations, recruitment
If you look at your organisation carefully, it is likely you will find three or even four generations represented among …
Latest news from Datamonitor
July 28, 2008Sales and Marketing Genentech, Roche
Roche looks to maximise Genentech potentialRoche has initiated efforts to acquire all outstanding shares in Genentech for approximately $43.7 billion, …
Pharma-Patient group relationships
July 24, 2008Research and Development, Sales and Marketing industry relations, patient groups, pharma
In the headlong race for global domination, pharma companies are in the process of flattening their hierarchies, slashing bureaucracy, streamlining …
Generics giant formed as Teva acquires Barr
July 24, 2008Sales and Marketing generics
Teva is to buy rival firm Barr for $7.5 billion to create a new giant in the global generics industry. …
Roche acquires gene therapy specialists Mirus
July 24, 2008Sales and Marketing
Roche has bought Mirus Bio for $125 million, a move which it believes will put it at the forefront of …
Pfizer thrives despite US slowdown
July 24, 2008Sales and Marketing
Pfizer has posted strong second quarter results despite underwhelming performance from its US operations. Outside the US Pfizer's revenue rose …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
